SQ Innovation, Inc. Report issue

For profit Phase 2
Founded: Zug Switzerland (2019)

Organization Overview

First Clinical Trial
2020
NCT04384653
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

SQ Innovation, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

furosemide (lasix) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Failure (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1